Wall Street analysts issued a flurry of rating changes and price-target revisions across more than 100 U.S. equities on 27–28 July, with technology and industrial names attracting the most bullish attention. Nasdaq Inc. led the upgrades after UBS lifted the exchange operator to Buy and boosted its target to $115 from $95. Barclays, RBC Capital Markets and Deutsche Bank followed with targets ranging from $105 to $109. ServiceNow received at least six target hikes, including matching highs of $1,250 from D.A. Davidson and Wells Fargo, underscoring optimism about the software maker’s pipeline ahead of earnings. Opinions diverged sharply on Tesla: China Renaissance cut the electric-vehicle maker to Hold with a $349 target, while Canaccord raised its target to $333 and kept a Buy rating. Nuclear-power start-up Oklo also split the Street; BNP Paribas began coverage at Underperform with a $14 target, but Daiwa launched at Buy and an $86 target the same day. Healthcare moves skewed negative. Wells Fargo downgraded oncology specialist NovoCure and reduced its target by two-thirds to $14, citing slower prescription growth, while HSBC lowered Thermo Fisher Scientific to Hold at a $510 target. Among consumer and industrial names, O’Reilly Automotive collected six Buy-equivalent ratings with a top target of $115. United Rentals saw its high-water mark rise to $960 at KeyBanc, and Jefferies upgraded Union Pacific to Buy with a $285 target. UBS’s $474 target for Quanta Services and Oppenheimer’s $800 call on Spotify highlighted further pockets of conviction. The breadth of revisions—spanning financials, energy, real estate and biotech—signals that analysts are recalibrating models ahead of the heart of second-quarter earnings season.